A pilot study of the tolerability, safety and efficacy of CPHPC in patients with systemic amyloidosis

被引：0
作者：
Gillmore, J. D. [1 ]
Offer, M. [1 ]
Lachmann, H. J. [1 ]
Goodman, H. J. [1 ]
Tennent, G. A. [1 ]
Gallimore, J. R. [1 ]
Pepys, M. B. [1 ]
Hawkins, P. N. [1 ]
机构：
[1] UCL, Natl Amyloidosis Ctr, London, England
来源：
AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS | 2006年 / 13卷
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：30 / 31
页数：2
相关论文
共 50 条
  • [1] Target Mediated Drug Disposition Model of CPHPC in Patients With Systemic Amyloidosis
    Sahota, T.
    Berges, A.
    Barton, S.
    Cookson, L.
    Zamuner, S.
    Richards, D.
    CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY, 2015, 4 (02): : 116 - 126
  • [2] PILOT STUDY TO INVESTIGATE THE TOLERABILITY AND EFFICACY OF DIETARY MANIPULATION IN PATIENTS WITH GASTROPARESIS AND SYSTEMIC SCLEROSIS
    Biddle, Kathryn
    Barnes, Theresa
    RHEUMATOLOGY, 2019, 58
  • [3] Efficacy, Safety, and Tolerability of Oral Furosemide Among Patients Receiving Hemodialysis: A Pilot Study
    Flythe, Jennifer E.
    Assimon, Magdalene M.
    Tugman, Matthew J.
    Narendra, Julia H.
    Singh, Simran K.
    Jin, Wanting
    Li, Quefeng
    Bansal, Nisha
    Hostetter, Thomas H.
    Dember, Laura M.
    KIDNEY INTERNATIONAL REPORTS, 2022, 7 (10): : 2186 - 2195
  • [4] A pilot study on the efficacy, tolerability and safety of safinamide in elderly Parkinson's disease patients
    Rinaldi, D.
    Sforza, M.
    Bianchini, E.
    Galli, S.
    Pontieri, F. E.
    MOVEMENT DISORDERS, 2020, 35 : S477 - S477
  • [5] Efficacy, safety and tolerability of tocilizumab in patients with systemic juvenile idiopathic arthritis
    Yokota, Shumpei
    Tanaka, Toshio
    Kishimoto, Tadamitsu
    THERAPEUTIC ADVANCES IN MUSCULOSKELETAL DISEASE, 2012, 4 (06) : 387 - 397
  • [6] Pilot study of cabozantinib efficacy, safety and tolerability in metastatic renal carcinoma in aged fragile patients
    Climent Duran, M. A.
    Basterretxea, L.
    Sanchez Escribano, R.
    Llabres, E.
    Heras Lopez, L.
    Zambrana, F.
    Torregrosa, M. D.
    Girones Sarrio, R.
    Villa Guzman, J. C.
    Juan Fita, M. J.
    Fernandez Nunez, N.
    ANNALS OF ONCOLOGY, 2020, 31 : S608 - S608
  • [7] A Pilot Study to Evaluate the Safety and Efficacy of Treprostinil in the Treatment of Calcinosis in Patients with Systemic Sclerosis
    Chung, Melody
    Valenzuela Vergara, Antonia Maria
    Catanese, Benjamin
    Li, Shufeng
    Stevens, Kate
    Chung, Lorinda
    ARTHRITIS & RHEUMATOLOGY, 2020, 72
  • [8] A pilot study of the safety and tolerability of etanercept in patients with alcoholic hepatitis
    Menon, KVN
    Stadheim, L
    Kamath, PS
    Wiesner, RH
    Gores, GJ
    Peine, CJ
    Shah, V
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2004, 99 (02) : 255 - 260
  • [9] Safety, Tolerability and Efficacy of Cael-101 in AL Amyloidosis Patients Treated on a Phase 2, Open-Label, Dose Selection Study to Evaluate the Safety and Tolerability of Cael-101 in Patients with AL Amyloidosis
    Khouri, Jack
    Anwer, Faiz
    Samaras, Christy J.
    Garcia, Alex V. Mejia
    Koc, Omer N.
    Faiman, Beth M.
    Hamilton, Kimberly
    Mathur, Saveta
    Scott, Cynthia
    Stefunek, Kathleen
    Sgobbo, Josephine
    Fada, Sherry
    Lewis, Brittany
    Shepherd, Kelly
    Ahmad, Naqib
    Knebusch, Madeleine
    Sobolov, Susan B.
    Jobes, Janet
    Daniel, Eileen
    Spector, Michael
    Valent, Jason
    BLOOD, 2020, 136
  • [10] A pilot tolerability and efficacy study of levetiracetam in patients with chronic myoclonus
    Frucht, SJ
    Louis, ED
    Chuang, C
    Fahn, S
    NEUROLOGY, 2001, 57 (06) : 1112 - 1114
12345